|
Session 1-2: Sustained-release, Controlled-release, and Modified-release |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Dr. Matteo Petrini, Head of Laboratory, Thermosome GmbH, Germany
|
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: TBD Dr. Matteo Petrini, Head of Laboratory, Thermosome GmbH, Germany |
|
09:25-09:50 |
Title: On Some Prospects and Benefits of Drug-templated Synthesis of Mesoporous Silica Nanocontainers Dr. Olga V. Dement’eva, Leading Researcher, Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences, Russia |
|
09:50-10:15 |
Title: Regulatory Framework for Complex off-patent Medicines. A Glimpse into Global Clinical Development Dr. Pavel Farkas, Senior Director, Global Gx Clinical R&D, PLIVA, Croatia |
|
10:15-10:30 |
Coffee Break |
|
Session 2-2: Nanotechnologies for Drug Delivery |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 3-2: Inhalation & Respiratory Drug Delivery |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Dr. Sinthia Bosnic-Anticevich, Professor, University of Sydney, Australia |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Drug Vaping: Assessment of Ecig as Thermal Aerosol Generation Device for Inhaled Bronchodilators Dr. Jeremie Pourchez, Professor, Mines Saint-Etienne, UMR INSERM U1059, France |
|
09:00-09:25 |
Title: Inhaler Devices: The Opportunities and Challenges of Getting It Right in Practice Dr. Sinthia Bosnic-Anticevich, Professor, University of Sydney, Australia |
|
09:25-09:50 |
Title: TBD Dr. David Brown, CEO and Founder, Teicos Pharma, Finland |
|
09:50-10:15 |
Title: Biophysical and Chemical Stability of Surfactant/Budesonide and the Pulmonary Distribution Following Intra-tracheal Administration Dr. Tsu-Fu Yeh, Professor, Taipei Medical University, Taiwan, China |
|
10:15-10:40 |
Speech Opportunity Available |
|
Session 4-1: Polymers for Drug Delivery |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Mr. Holger Krenz, Vice President Applications Development Europe, SiO2 Medical Products, Germany |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: Its Time to Rethink Glass: Transformative Parenteral Packaging through Advanced Materials Science Mr. Holger Krenz, Vice President Applications Development Europe, SiO2 Medical Products, Germany |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 1-3: Transdermal and Intradermal Delivery |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Dr. Stef Stienstra, Professor, Dutch Armed Forces/Royal Dutch Navy, the Netherlands |
| Co-chair |
Dr. Marina Komaroff, Senior Director, Biostatistics – Product Development, Noven Pharmaceuticals, Inc., USA |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: Drug Delivery by Tattooing for the Treatment of Cutaneous Leishmaniasis Dr. Stef Stienstra, Professor, Dutch Armed Forces/Royal Dutch Navy, the Netherlands |
|
14:25-14:50 |
Title: Transdermal Drug and Protein Interaction Characterization via Non-invasive Terahertz Imaging and Spectroscopy Dr. Anis Rahman, President & CTO, Applied Research & Photonics, Inc., USA |
|
14:50-15:15 |
Title: Engineering Advanced Microneedles for Delivery of Living Therapeutics Dr. Hao Chang, Department of Polymer Science & Engineering, Zhejiang University, China |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Speech Opportunity Available |
|
15:55-16:20 |
Title: TBD Dr. Marina Komaroff, Senior Director, Biostatistics – Product Development, Noven Pharmaceuticals, Inc., USA |
|
16:20-16:45 |
Speech Opportunity Available |
|
16:45-17:10 |
Title: Biomedical Engineer - Pharmaceuticals Dr. Romina Doubnia, Project Leader, Operational Excellence, Aveva Drug Delivery Systems, USA |
|
Session 2-3: Nucleic Acid Delivery and Vaccine Delivery |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Dr. Shalini Andersson, Chief Scientist, AstraZeneca, Sweden |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available
|
|
14:00-14:25 |
Title: Delivery of Nucleic Acid Therapeutics: Challenges and Opportunities Dr. Shalini Andersson, Chief Scientist, AstraZeneca, Sweden |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Speech Opportunity Available |
|
15:15-15:30 |
Coffee Break |
|
Session 3-3: Brain Drug Delivery |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Dr. Rachita K. Sumbria, Associate Professor, Keck Graduate Institute, USA |
|
Co-Chair |
Dr. Hemant Sarin, Translational Scientist, Translational Science and Medicine, USA |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: TBD
Dr. Amgad Hanna, Professor, Department of Neurosurgery, University of Wisconsin, USA |
|
14:25-14:50 |
Title: Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease Dr. Rachita K. Sumbria, Associate Professor, Keck Graduate Institute, USA |
|
14:50-15:15 |
Title: Theranostic Detection of Systemic or Locoregional Drug Delivery through Cellular Barriers
Dr. Hemant Sarin, Translational Scientist, Translational Science and Medicine, USA |
|
15:15-15:30 |
Coffee Break |
|
Session 4-2: Nanoparticles and Nanocapsules in Drug Delivery |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Dr. Silvio Dutz, Professor, Technische Universität Ilmenau, Germany |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: TBD Dr. Mazhar I. Khan, Professor, Department of Pathobiology and Institute of Material Science, University of Connecticut, USA |
|
14:00-14:25 |
Title: Investigation of Magnetically Driven Passage of Magnetic Nanoparticles through Eye Tissues for Magnetic Drug Targeting Dr. Silvio Dutz, Professor, Technische Universität Ilmenau, Germany |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Title: Quality by Design Based Development and Validation of HPLC Method for Simultaneous Estimation of Paclitaxel and Vinorelbine Tartrate in Dual Drug Loaded Liposomes Dr. Smita Bonde, Associate Professor, School of Pharmacy & Technology Management, SVKMs NMIM, India |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 | Speech Opportunity Available |
| 15:55-16:20 |
Title: Development of a Vaginal Administration of anti-HIV Microbicide Nanosystem Dr. Li Li, Research Fellow, The University of Queensland, Australia |
| 16:20-16:45 | Speech Opportunity Available |
| 16:45-17:10 | Title: Mitochondria-targeted Antioxidant MitoQ Prevents mCa2+-Mediated Mitochondrial Permeability Transition and Fission for Protection during mCa2+ Stress in RBA-1 Astrocytes
Dr. Mei-Jie Jou, Associate Professor, Department of Physiology & Pharmacology, Chang Gung University, Taiwan |
|
© 2003-2022 All rights reserved by BIT Group Global Ltd. |